. 2016 Mar 4;11(3):e0149856. doi: 10.1371/journal.pone.0149856

Table 2. Number of Patients Receiving IVD Testing per Week and General Use of IVD Testing During Different Phases of Care.

			Patients treated with IVD			General use of IVD (%)
Country	Specialty	Setting	Mean No. of patients/week	Patients with IVD testing (%)	Clinical decisions affected by IVD (%)	Initial diagnosis	Treatment monitoring	Post-treatment monitoring
US
	Oncologist	Total	62	91	58	95	95	79
		Private	87	94	62	97	97	81
		Hospital	45	88	54	92	92	76
	Cardiologist	Total	86	62	68	86	52^a	52^a
		Private	99	42	59	79	44^a	44^a
		Hospital	74	80	76	93	61^a	61^a
	Average US		74	74	64	90	71	64
Germany
	Oncologist	Total	114	92	63	100	94	87
		Private	95	88	58	99	92	77
		Hospital	133	96	67	100	96	95
	Cardiologist	Total	112	59	71	75	68^a	68^a
		Private	175	35	64	57	51^a	51^a
		Hospital	95	92	80	99	90^a	90^a
	Average Germany		113	76	67	87	81	78
Overall
Average oncologists			88	92	62	97	94	84
Average cardiologists			99	60	70	82	61^a	61^a
Average Overall (%)				75	66	88	77	72
Average Overall (in No. of patients/week)			93	71	61

IVD, in vitro diagnostics. ^aFor cardiologists, only one question was asked on treatment monitoring and post-treatment monitoring.